Acted for French pharmaceutical company — supervisory board compliance — Russia Client. A French pharmaceutical manufacturer operating in Russia through a wholly owned subsidiary registered in the Siberian Federal District, active in the production
Acted for French pharmaceutical company — supervisory board compliance — Russia
Client. A French pharmaceutical manufacturer operating in Russia through a wholly owned subsidiary registered in the Siberian Federal District, active in the production and distribution of prescription medicines under a Russian Ministry of Health licence.
Background. Following a change in Russian corporate legislation governing the composition and competencies of supervisory boards in strategic and licensed sectors, the client's Russian subsidiary was found to have a supervisory board structure that no longer complied with mandatory requirements applicable to entities with foreign participation in the pharmaceuticals sector. Regulatory scrutiny created material risk to the subsidiary's operating licence and threatened the client's ability to distribute product through its Russian entity. The matter required rapid analysis of the applicable corporate law framework, coordination with the Russian pharmaceutical regulator, and restructuring of the supervisory board within a compressed timeline to avoid licence suspension.
Our role. Counsel advised the client on the mandatory supervisory board composition requirements under Russian corporate and sector-specific legislation, prepared the legal analysis underpinning the restructuring decision, and drafted the necessary corporate resolutions and ancillary documentation. Counsel coordinated directly with the subsidiary's local management and liaised with external regulatory contacts to confirm compliance status with the relevant supervisory authority prior to the licence renewal date.
Outcome. Full compliance with supervisory board requirements achieved and operating licence renewed without interruption — full recovery achieved. The restructuring was completed within 11 months of instruction, ahead of the regulatory deadline.
Discuss a similar matter — info@vetrovpartners.com
This briefing is general information and does not constitute legal advice. For advice on a specific matter, write in confidence to info@vetrovpartners.com.
Our team advises foreign clients on exactly these questions across Russia and the EAEU region. Initial 30-minute consultation — complimentary.
Make an enquiry